RN7SL471P

Across TCGA pan-cancer cohorts, RN7SL471P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RN7SL471P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RN7SL471P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL471P expression acts as an unfavorable survival marker, although some lineages such as ESCA and PCPG show a favorable association.

ESCA, BRCA, and READ are the cancer types where RN7SL471P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Median	III,IV	0.592	0.309	.001	60	view →
BRCA	OS	Tertile	IV	0.275	0.780	.027	54	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	45	view →
UVM	OS	Median	III,IV	0.245	0.836	.002	43	view →
KIRC	DFS	Tertile	IV	0.343	0.643	.014	36	view →
PAAD	DFS	Tertile	III,IV	0.275	0.794	.008	30	view →
SKCM	DFS	Tertile	All	0.668	0.870	.001	27	view →
LUSC	DFS	Tertile	II,III,IV	0.606	0.717	.026	27	view →
PCPG	DFS	Tertile	All	1.000	0.731	.011	18	view →
LIHC	DFS	Tertile	II,III,IV	0.777	0.277	.011	9	view →
STAD	DFS	Median	IV	0.646	0.215	.023	6	view →
BLCA	DFS	Tertile	III,IV	0.655	0.525	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RN7SL471P–ESCA (DFS)

Open the ESCA breakdown →